Your browser doesn't support javascript.
loading
Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma.
Sethi, Tarsheen K; Kovach, Alexandra E; Grover, Natalie S; Huang, Li-Ching; Lee, Laura A; Rubinstein, Samuel M; Wang, Yang; Morgan, David S; Greer, John P; Park, Steven I; Ann Thompson-Arildsen, Mary; Yenamandra, Ashwini; Vnencak-Jones, Cindy L; Reddy, Nishitha M.
Afiliación
  • Sethi TK; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kovach AE; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Grover NS; Division of Hematology-Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Huang LC; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Lee LA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rubinstein SM; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Wang Y; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Morgan DS; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Greer JP; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Park SI; Levine Cancer Institute, Charlotte, NC, USA.
  • Ann Thompson-Arildsen M; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Yenamandra A; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Vnencak-Jones CL; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Reddy NM; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Leuk Lymphoma ; 60(12): 2880-2889, 2019 12.
Article en En | MEDLINE | ID: mdl-31184237
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transducción de Señal / Neoplasias del Sistema Nervioso Central / Factor 88 de Diferenciación Mieloide / Receptor de Muerte Celular Programada 1 / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transducción de Señal / Neoplasias del Sistema Nervioso Central / Factor 88 de Diferenciación Mieloide / Receptor de Muerte Celular Programada 1 / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos